Markets:

Overview

News

Currencies

International

Treasuries

Pharmather Hldgs Ltd (OP:PHRRF)

0.0402 UNCHANGED

Streaming Delayed Price Updated: 3:58 PM EDT, Jun 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pharmather Hldgs Ltd

< Previous 1 2 3 4 5 Next >

Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program ↗

October 11, 2021

The Week In Psychedelics

Via Benzinga

Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction ↗

October 04, 2021

The Week In Psychedelics:

Via Benzinga

Senate Bill Decriminalizing Psychedelics Could Help Reverse Some “War on Drugs” Impacts

September 22, 2021

Via FinancialNewsMedia

These OTC Securities Had the Most Trading Activity in June ↗

July 20, 2021

Photo by Cris Ovalle on Unsplash OTC Markets trading volume was still led by cryptocurrencies and cannabis for the month of June, but many other securities shined comparatively as...

Via Benzinga

Topics Cannabis

How To Invest In "Magic Mushrooms" (Psychedelics) ↗

July 09, 2021

A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest.

Via Talk Markets

Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies ↗

July 02, 2021

Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o...

Via Benzinga

Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More ↗

June 30, 2021

Institutional analysts are taking a liking to the industry ...

Via Benzinga

Psyched: MindMed To Begin Mescaline Trials and Deepak Chopra Partnership, Seelos And Cybin Advance Clinical Research ↗

May 24, 2021

MindMed’s News Spree: Mescaline Trials, Chopra Foundation Partnership and LSD Research MindMed (NASDAQ:

Via Benzinga

Psyched: MindMed, Atai Head For Nasdaq, Psychedelics Search Platforms Grow, Champignon Brands Resumes Trading ↗

April 26, 2021

Two of the most highly funded companies in the psychedelics space announced plans last week to list on the Nasdaq exchange. Months after ...

Via Benzinga

Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027

April 14, 2021

Via FinancialNewsMedia

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.